Jason Zemansky
Stock Analyst at B of A Securities
(4.2)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Upgrades: Buy | 4 10 | 3.64 | 174.73% | 2 | Aug 20, 2025 | |
INSM Insmed | Maintains: Strong Buy | 94 109 | 131.65 | -17.2% | 10 | Jun 11, 2025 | |
KROS Keros Therapeutics | Downgrades: Neutral | 32 18 | 15.67 | 14.87% | 2 | Jun 10, 2025 | |
CYTK Cytokinetics | Maintains: Neutral | 62 54 | 38.49 | 40.3% | 4 | Apr 15, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 29 31 | 17.95 | 72.7% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 22 17 | 10.59 | 60.53% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 29 | 7.63 | 280.08% | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 31 | 16.3 | 90.18% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 3 | 2.15 | 16.28% | 5 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 391 23 | 9.81 | 134.45% | 2 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 230 | 18.2 | 1163.74% | 1 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 10 | 1.32 | 657.58% | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 162 | 0.93 | 17319.35% | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 145 155 | n/a | n/a | 2 | Dec 13, 2021 |